Ensysce Biosciences (ENSC) Accounts Payables (2020 - 2025)
Historic Accounts Payables for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to $463458.0.
- Ensysce Biosciences' Accounts Payables fell 7644.52% to $463458.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $463458.0, marking a year-over-year decrease of 7644.52%. This contributed to the annual value of $1.4 million for FY2024, which is 2990.32% down from last year.
- Per Ensysce Biosciences' latest filing, its Accounts Payables stood at $463458.0 for Q3 2025, which was down 7644.52% from $1.0 million recorded in Q2 2025.
- Ensysce Biosciences' Accounts Payables' 5-year high stood at $3.1 million during Q2 2021, with a 5-year trough of $301104.0 in Q4 2021.
- For the 5-year period, Ensysce Biosciences' Accounts Payables averaged around $1.4 million, with its median value being $1.2 million (2022).
- The largest annual percentage gain for Ensysce Biosciences' Accounts Payables in the last 5 years was 181873.58% (2021), contrasted with its biggest fall of 8254.06% (2021).
- Quarter analysis of 5 years shows Ensysce Biosciences' Accounts Payables stood at $301104.0 in 2021, then surged by 877.67% to $2.9 million in 2022, then crashed by 34.23% to $1.9 million in 2023, then fell by 29.9% to $1.4 million in 2024, then tumbled by 65.85% to $463458.0 in 2025.
- Its Accounts Payables was $463458.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $615295.0 in Q1 2025.